The Anti-Money Laundering Council has so far secured freeze orders covering 727 bank accounts, 73 vehicles, 18 properties, and 30 insurance policies On September 16, the Anti-Money Laundering Council ...

Trump Says He’s Bringing $15 Billion Lawsuit Against New York Times Tony Stewart Issues Update After Horrific NHRA Crash In Pennsylvania ‘The Love Boat’ cast sets sail again with reunion: The stars ...

Casinos are once again back in the spotlight following claims that they are the preferred venue of public officials to “clean” money allegedly siphoned from government projects, particularly those ...

Managing glucose levels during pregnancy in women with type 1 diabetes is important for the mother and child. New technology helped women with type 1 diabetes maintain target glucose levels during ...

CHICAGO — Once-weekly semaglutide improved glycemia and reduced weight without increasing hypoglycemia in adults with type 1 diabetes (T1D) and obesity, new research presented at the American Diabetes ...

CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a randomized trial showed. In this 26-week, double-blind trial of 72 adults, 36% who ...

Craftee reveals why XP could now control your IQ in Minecraft. Iran issues warning after U.S. helps Israel intercept missiles Brian Wilson's health struggles included dementia, schizoaffective ...

CEO John Sheridan highlighted that Tandem achieved over 20% growth for the third consecutive quarter, with record sales both in the U.S. and internationally. The company's operational focus on ...

Among pediatric patients with T1D, 90-day time in range was similar between those who used the Insulet Omnipod 5 or the Tandem Control IQ. US youth with type 1 diabetes (T1D) who use the 2 most common ...

Tandem Diabetes Care, Inc. TNDM recently commercially launched Control-IQ+ technology - the latest generation of its advanced hybrid closed-loop algorithm in the United States. Control-IQ+ is ...

Tandem Diabetes (TNDM) Care announced publication by The New England Journal of Medicine of results from the company’s pivotal trial of Control-IQ+ automated insulin delivery technology in people with ...

Tandem Diabetes Care Inc.’s Control-IQ+ automated insulin delivery system improved multiple measures of glycemic control in individuals with type 2 diabetes who use insulin, a study presented March 19 ...